News
4317 posts · page 121 of 180
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Gains?
Molbio Diagnostics seeks ₹940 crore through IPO, aiming to fund expansion and reduce promoter stake.
Thyrocare Promoter Sells 9.9% Stake for Rs 986 Crore
Docon Technologies offloaded a significant stake in Thyrocare, reducing its holding to 51.02%.
Surrogate Birth Sparks Legal Battle Over Custody After Medical Dispute
A surrogate mother is contesting custody after giving birth in Texas amid a conflict over the baby's health diagnosis.
Medical Device Industry Criticizes India's Draft Regulation Bill
India's medical device industry opposes a 2026 bill treating devices like drugs, citing potential harm to innovation and investment.
Abhay Soi Challenges Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against capping private hospital room rents, citing investment needs.
Cardiologist Questions Trump's Health Management Amid Scrutiny
A cardiologist raises seven concerns about former President Trump's healthcare, sparking debate over his medical regimen.
Cardiologist Highlights 6 Key Signs Your Heart Might Be in Trouble
Experiencing a racing heart after coffee? A cardiologist outlines six symptoms that could indicate serious heart issues.
Activist Devendra Mahto Requests Medical Clearance for Protest Return
Activist Devendra Mahto seeks approval from a civil surgeon to resume his protest activities.
Exploring Obsession: The Monster and the Surgeon Reviewed
The Guardian's review delves into a gripping tale of obsession and surgery, challenging readers with its intense narrative.
Surgeon Vice Admiral Arti Sarin Reflects on Military Medical Service
Surgeon Vice Admiral Arti Sarin shares insights from her four decades in military healthcare.
Molbio Diagnostics IPO Targets ₹200 Crore for Expansion
Molbio Diagnostics plans to raise ₹200 crore through an IPO, aiming to expand its manufacturing and reduce promoter stakes.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies sold a 9.9% stake in Thyrocare Technologies for Rs 986 crore to institutional investors via NSE and BSE.
Surrogate Fights for Custody After Giving Birth Amid Legal Dispute
A surrogate in Texas battles for custody after biological parents sought to terminate the pregnancy due to a fetal heart defect.
Medical Device Industry Opposes Draft Bill, Cites Regulatory Concerns
India's medical device sector contests the draft bill equating devices with drugs, fearing stifled innovation and investment.
Abhay Soi Criticizes Proposed Price Caps on Private Hospitals
Max Healthcare's Abhay Soi argues against capping room prices, citing investment needs.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Growth?
Molbio Diagnostics aims to raise ₹200 crore for expansion while reducing promoter stake through a ₹740 crore offer for sale.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests a 9.9% stake in Thyrocare, raising Rs 986 crore through NSE and BSE transactions.
Surrogate Birth Sparks Legal Battle with Biological Parents
A surrogate mother is fighting for custody after giving birth amid a dispute over a pregnancy termination request.
Medical Device Firms Challenge Draft Bill's Pharma-Like Regulations
India's medical device sector opposes a draft bill treating devices like drugs, citing risks to innovation and investment.
Abhay Soi Challenges Proposed Cap on Private Hospital Room Rates
Max Healthcare's Abhay Soi argues against a blanket cap on private hospital room rates, citing investment viability concerns.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloaded nearly 10% of its stake in Thyrocare Technologies, raising Rs 986 crore through NSE and BSE deals.
Medical Device Industry Rejects Draft Bill's Pharma Approach
India's medical device sector opposes a draft bill equating devices with drugs, citing risks to innovation.
Abhay Soi Criticizes Price Caps on Private Hospital Rooms
Max Healthcare's Abhay Soi argues that price caps on hospital rooms could hinder investment in new facilities.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloaded a 9.9% stake in Thyrocare, raising Rs 986 crore through NSE and BSE transactions.